22 January 2021
Dr Hussain joins DEBRA on 25th January to lead the charity’s research strategy, funding pioneering research to help alleviate the symptoms but ultimately find a cure.
28 October 2020
A new spray for treating severely painful blisters, mouth ulceration and oral scarring in patients with a rare genetic skin condition is being developed by researchers at the University of Birmingham.
11 September 2020
We are excited to share the positive results of a global trial by Amyrt Pharma of a topical therapeutic gel treatment which could potentially increase the speed of wound healing for people affected by Epidermolysis Bullosa (EB).
7 April 2020
RenovaCare Inc. have announced that the Company’s novel SkinGun™ is now being used to apply regenerative cells in a preclinical study of new gene therapies, underway at King’s College London.
29 January 2020
Dr Maria Papanikolaou shares her experience of visiting the Miami Itch Center with the support of DEBRA UK. Dr Papanikolaou is currently working on the PRUMEC trial, which focuses on explaining the cause of itch in an inherited skin condition known as Dystrophic Epidermolysis Bullosa.